Treatment of Hospital Acquired Pneumonia (HAP) with Persian medicine (PM): A Case Report
-
Hoorieh Mohammadi Kenari
,
Gholamreza Kordafshari
,
Mohammad Kamalinejad
,
Somayeh Aghighi
,
Maryam Moghimi
Abstract
Hospital acquired pneumonia (HAP) caused by resistant microorganisms is one of the common reasons of mortality in hospitalized patients, which causes many complications and costs. In addition, nutritional support of a patient with pneumonia is very important. In this article, we present a case of pneumonia in which the therapeutic and nutritional instructions of Persian Medicine (PM) saved a patient’s life. The patient suffered from multiple trauma, affected by HAP during hospitalization. He was treated with a variety of broad-spectrum antibiotics for 9 days, but no improvement in the fever and respiratory state was observed, and eventually he was intubated and transferred to the ICU. Due to lack of improvement, he was treated with PM. One day after starting the treatment with PM, fever was reduced and was discontinued the following day. Three days later, the respiratory state improved and the chest X-ray was normal. Eventually, after 6 days the patient was discharged from the ICU.
Before starting the PM orders, despite the administration of multiple antibiotics, due to the lack of proper diet, there was no satisfactory response to treatment. The therapeutic approach of PM began with diet modification and improvement of the patient's digestive system and simultaneously benefited from herbal medicines to improve the patient's pulmonary status. The therapeutic methods of PM with special attention to temperament and the individual type of treatment and nutrition can be useful in many cases where conventional therapies do not improve the complications of the disease.
Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. 17th ed. McGraw-Hill Medical Publishing Division. New York 2008.
Gastmeier P, Sohr D, Geffers C, Behnke M, Ruden H. Risk factors for death due to nosocomial infection in intensive care unit patients: findings from the Krankenhaus Infektions Surveillance System. Infect Control Hosp Epidemiol 2007;28:466-472.
Larijani B, Moghimi M. Common Types of Diabetic Dosage Forms in Medieval Persia. Pharm Hist (Lond) 2015;45:96-99.
Avicenna. Qanun fi al Tib [Canon of Medicine]. Ehyaol Toras al-Arabi Press. Beirut 2010.
Razes. Al Havi [Liber Continent]. Vol 1. Ehyaol Toras al-Arabi Press. Beiruot 2001.
Jorjani I. Zakhireye Kharazmshahi (Treasure of the Khwarazm Shah). Jalaleddin Press. Qom 2011.
Kermani MK. Daqaeq-al Alaj. Saadat Press. 1983.
Chashti MA (Nazem Jahan). Exir e Azam [Great Elexir]. Vol 3. 1st ed. Iran: Research Institute for Islamic and Complementary Medicine. Tehran 2008.
Arzani MA. Teb-e-Akbari [Akbari’s Medicine]. Jalaleddin Press. Qom 2008.
Aghili Khorasani MH. Makhzan-ol-Adviyah [Storehouse of Medicaments]. Tehran University of Medical Sciences. Tehran 2009.
Tonekaboni HM. Tohfat al momenin [A Gift for the Faithful]. Research Center of Traditional Medicine. Shahid Beheshti University of Medical Sciences.Nashre Shahr Press. Tehran 2007.
Aghili Khorasani Shirazi MH. Qarabadin-e-Kabir. mahmoudi Press. Tehran 1970.
Borugă O, Jianu C, Mişcă C, Goleţ I, Gruia A, Horhat FG. Thymus vulgaris essential oil: chemical composition and antimicrobial activity. J Med Life 2014;7:56-60.
Ahmad A, Van Vuuren S, Viljoen A. Unravelling the complex antimicrobial interactions of essential oils--the case of Thymus vulgaris (thyme). Molecules 2014;19:2896-2910.
Mancini E, Senatore F, Del Monte D, De Martino L, Grulova D, Scognamiglio M, Snoussi M, De Feo V. Studies on Chemical Composition, Antimicrobial and Antioxidant Activities of Five Thymus vulgaris L. Essential Oils. Molecules. 2015;20:12016-12028.
Seibel J, Pergola C, Werz O, Kryshen K, Wosikowski K, Lehner MD, Haunschild J. Bronchipret® syrup containing thyme and ivy extracts suppresses bronchoalveolar inflammation and goblet cell hyperplasia in experimental bronchoalveolitis. Phytomedicine. 2015;22:1172-1177.
Boukraa L, Bouchegrane S, Additive action of honey and starch against Candida albicans and Aspergillus niger. Rev Iberoam Micol. 2007;24:309-311.
Al-Waili NS, Salom K, Butler G, Al Ghamdi AA. Honey and Microbial Infections: A Review Supporting the Use of Honey for Microbial Control. J Med Food. 2011;22:6-9.
Shadkam MN, Mozaffari-Khosravi H, Mozayan MR, A comparison of the effect of Honey, dextromethorphan, and diphenhydramine on nightly cough and sleep quality in children and their parents. J Altern Complement Med 2010;16:787-793.
Quave CL, Plano LR, Pantuso T, Bennett BC. Effects of extracts from Italian plants on planktonic growth, biofilm formation and adherence of methicillin-resistant Staphylococcus aureus. J Ethnopharmacol 2008;118:418-428.
Takeda S, Tatara I, Kono K, Arakawa K. Relation between nutrition of patiens and methicillin- resistant Staphylococcus aureus (MRSA). Kansenshogaku Zasshi. 1996;70: 354-359.
Rivera DG, Hernandez I, Merino N, Luque Y, Alvarez A, Martin Y, Amador A, Nuevas L, Delgado R. Magnifera indica L. extract (vimang) and magiferin reduce the airway inflammation and Th2 cytokines in murine model of allergic asthma. J Pharm Pharmacol 2011;69:1336-1345.
Garrido G, Delgado R, Lemus Y, Rodriguez J, Garcia D, Nunez-Selles AJ. Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production on macrophages and microglia by a standard aqueous extract of Magnifera indica L. Pharmacol Res 2004;50:165-172.
Hernandez P, Rodriguez PC, Delgado R, walczak H. Protective effect of Magnifera indica L. polyphenols on human T lymphocytes against activation-induced cell death. Pharmacol Res 2007;55:167-170.
Garrido G, Gonzalez D, Lemus Y, Garcia D, Lodiero L, Quintero G, Delporte C, Nunez-Selles AJ, Delgado R. In vivo and in vitro anti-inflammatory activity of Magnifera indica L. extract(Vimang). Pharmacol Res 2004;50:143-149.
Zhou HF, Xie C, Jian R, Kang J, Li Y, Zhuang CL, Yang F, Zhang LL, Lai L, Wu T, Wu X. Biflavonoids from Caper (Capparis spinosa L.) fruits and their effects in inhibiting NF-kappa B activation. J Agric Food Chem 2011;59:3060-3065.
Zhou H, Jian R, Kang J, Huang X, Li Y, Zhuang C, Yang F, Zhang L, Fan X, Wu T, Wu X. Anti-inflammatory effects of Caper (Capparis spinosa L.) fruit Aqueous extract and the isolation of main Phytochemicals. J Agric Food Chem 2010;58:12717-12721.
Mahasneh A. Screening of some indigenous Qatari medicinal plants for antimicrobial activity. Phytother Res 2002;16:751-753.
| Files | ||
| Issue | Vol 3, No 2, 2018 | |
| Section | Case Studies | |
| Keywords | ||
| Hospital acquired pneumonia (HAP) Conventional medicine Persian medicine Treatment | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
